Shin Nippon Biomedical Laboratories Ltd 2024 Integrated Report
Company: Shin Nippon Biomedical Laboratories Ltd
Sector: Professional & technical services
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 12
The report presents SNBL's FY3/2024 performance and strategy in an integrated report. It records revenue of 26,450 million yen and 1,341 employees at fiscal-year end. Group environmental data includes 5,452 t-CO2 Scope 1 emissions, 11,895 t-CO2 market-based Scope 2 emissions, 26,945 t-CO2 Scope 3 emissions, and 514 t waste. It also describes a double-materiality approach, Board-supervised SDGs Committee, and a FY3/2031 net-zero target.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.